Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21929245 | 0.89 | CLK4 (0.34) | TNKSADORA2A | |
| SCHEMBL21931854 | 0.88 | TNKS (0.37) | TNKSCYP19A1ADORA2AGSK3B | |
| SCHEMBL21931774 | 0.87 | TNKS (0.38) | TNKSCYP19A1ADORA2APTGER4PDPK1 | |
| SCHEMBL21929093 | 0.83 | CYP19A1 (0.32) | CYP19A1ADORA2ACYP11B2 | |
| SCHEMBL21950719 | 0.82 | TNKS (0.37) | TNKSCYP19A1ADORA2A | |
| SCHEMBL21414109 | 0.81 | TNKS (0.35) | TNKSADORA2A | |
| SCHEMBL21928558 | 0.81 | ATM (0.40) | PTGER4PDPK1CYP11B2 | |
| SCHEMBL21928329 | 0.81 | CYP1A2 (0.32) | TNKSCYP19A1PTGER4CYP11B2 | |
| SCHEMBL23098137 | 0.80 | CYP11B2 (0.39) | PTGER4CYP11B2 | |
| SCHEMBL21928443 | 0.79 | PTGER4 (0.39) | TNKSPTGER4PDPK1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | CYNORA GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
| EP-3609978-B1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-03-17 | — | — | EP | disclosed |
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OGFR, OR51E2 | TNKS 2167/4885CYP19A1 1182/4885ADORA2A 3091/4885 |
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | ALDH1A2, AOX1, CYBA | TNKS 1543/4885CYP19A1 161/4885ADORA2A 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.